Correlation Between Milestone Pharmaceuticals and Dyadic International
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Dyadic International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Dyadic International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Dyadic International, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Dyadic International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Dyadic International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Dyadic International.
Diversification Opportunities for Milestone Pharmaceuticals and Dyadic International
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Milestone and Dyadic is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Dyadic International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyadic International and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Dyadic International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyadic International has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Dyadic International go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Dyadic International
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to under-perform the Dyadic International. But the stock apears to be less risky and, when comparing its historical volatility, Milestone Pharmaceuticals is 1.05 times less risky than Dyadic International. The stock trades about -0.02 of its potential returns per unit of risk. The Dyadic International is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 140.00 in Dyadic International on August 26, 2024 and sell it today you would earn a total of 53.00 from holding Dyadic International or generate 37.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Dyadic International
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Dyadic International |
Milestone Pharmaceuticals and Dyadic International Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Dyadic International
The main advantage of trading using opposite Milestone Pharmaceuticals and Dyadic International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Dyadic International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyadic International will offset losses from the drop in Dyadic International's long position.The idea behind Milestone Pharmaceuticals and Dyadic International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Dyadic International vs. Eliem Therapeutics | Dyadic International vs. HCW Biologics | Dyadic International vs. Scpharmaceuticals | Dyadic International vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |